GBCS (Selectis Health) Notes Receivable: $0.00 Mil (As of Mar. 2026)


GBCS Selectis Health Inc GBCS
45 GF Score
Price $5.21
GF Value $2.14
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Selectis Health Notes Receivable?

Selectis Health GBCS 45 Notes Receivable is $0.00 Mil as of Mar. 2026. GuruFocus rates GBCS with a GF Score™ of 45/100 and a GF Value™ of $2.14 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Selectis Health's Notes Receivable for the quarter that ended in Mar. 2026 was $0.00 Mil.

Selectis Health Notes Receivable Related Terms

Selectis Health Notes Receivable Historical Data

* Premium members only.

The historical data trend for Selectis Health's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Selectis Health Notes Receivable Chart

Selectis Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Selectis Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
GBCS
45GF Score
Selectis Health Inc GBCS
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Selectis Health Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.00 Mil mean?
Selectis Health (GBCS) has a Notes Receivable of $0.00 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Selectis Health and its competitors.
Is Selectis Health's Notes Receivable too high?
Selectis Health's current Notes Receivable is $0.00 Mil. Overall, Selectis Health has a GF Score™ of 45/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Selectis Health's Notes Receivable compare to CCM and BMGL?
Selectis Health's Notes Receivable of $0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Healthcare Providers & Services company?
A good Notes Receivable depends on the Healthcare Providers & Services industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Selectis Health and its competitors. Selectis Health's current Notes Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Selectis Health stock overvalued right now?
Based on GuruFocus' analysis, Selectis Health (GBCS) is currently considered Significantly Overvalued. The stock's GF Value™ is $2.14, compared to a current price of $5.21 — trading 143.5% above its estimated fair value. The current Notes Receivable is $0.00 Mil. Selectis Health's overall GF Score™ is 45/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Selectis Health (GBCS), the current Notes Receivable is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Selectis Health (GBCS) Overvalued in 2026?

Based on GuruFocus' analysis, Selectis Health stock appears to be overvalued. The current stock price of $5.21 is trading 143.5% above its estimated GF Value™ of $2.14. GuruFocus considers Selectis Health to be Significantly Overvalued.

Key valuation signals for GBCS:

  • Notes Receivable: $0.00 Mil
  • GF Value™: $2.14 vs. price of $5.21 (143.5% above fair value)
  • GF Score™: 45/100 with 7 warning signs

No single metric tells the full story. See the GBCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Selectis Health Business Description

Address 600 17th Street, Suite 284, Denver, CO, USA, 80202
Selectis Health Inc owns and operates medical care facilities in the healthcare industry. The company acquires, develops, leases, and manages healthcare real estate and provides healthcare operations through its wholly-owned subsidiaries. The portfolio is comprised of investments in the following healthcare operations: (i) senior housing (including independent and assisted living) and (ii) post-acute/skilled nursing. It makes investments within the healthcare operations using the following six investment products: (i) direct ownership of properties, (ii) debt investments, (iii) developments and redevelopments, (iv) investment management, (v) the Housing and Economic Recovery Act of 2008, which represents investments in senior housing operations, and (vi) owning healthcare operations.
45GF Score

Get the complete analysis for GBCS

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.21
Price
$2.14
GF Value